Renaissance Technologies’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,502,100
Closed -$170M 3872
2019
Q3
$170M Sell
2,502,100
-312,400
-11% -$21.2M 0.14% 145
2019
Q2
$164M Buy
2,814,500
+435,000
+18% +$25.3M 0.14% 154
2019
Q1
$167M Buy
2,379,500
+432,400
+22% +$30.3M 0.15% 148
2018
Q4
$125M Buy
1,947,100
+164,000
+9% +$10.6M 0.14% 156
2018
Q3
$125M Buy
1,783,100
+378,176
+27% +$26.6M 0.13% 167
2018
Q2
$70.8M Buy
1,404,924
+222,324
+19% +$11.2M 0.08% 304
2018
Q1
$37M Buy
1,182,600
+170,600
+17% +$5.34M 0.04% 572
2017
Q4
$34.6M Buy
1,012,000
+141,300
+16% +$4.83M 0.04% 613
2017
Q3
$27.9M Buy
870,700
+57,400
+7% +$1.84M 0.03% 697
2017
Q2
$26.5M Buy
813,300
+80,100
+11% +$2.61M 0.03% 695
2017
Q1
$23.1M Buy
733,200
+156,500
+27% +$4.93M 0.03% 717
2016
Q4
$16.9M Buy
576,700
+29,100
+5% +$855K 0.03% 893
2016
Q3
$15.8M Buy
547,600
+111,500
+26% +$3.22M 0.03% 852
2016
Q2
$11.3M Sell
436,100
-9,921
-2% -$257K 0.02% 1067
2016
Q1
$11M Buy
446,021
+156,421
+54% +$3.87M 0.02% 1071
2015
Q4
$10.2M Buy
289,600
+55,800
+24% +$1.96M 0.02% 978
2015
Q3
$4.95M Sell
233,800
-33,400
-13% -$707K 0.01% 1406
2015
Q2
$7.43M Buy
267,200
+230,300
+624% +$6.4M 0.02% 1170
2015
Q1
$1.13M Buy
36,900
+24,700
+202% +$754K ﹤0.01% 2246
2014
Q4
$390K Buy
+12,200
New +$390K ﹤0.01% 2505
2014
Q2
Sell
-108,555
Closed -$2.86M 3073
2014
Q1
$2.86M Buy
108,555
+55,654
+105% +$1.47M 0.01% 1582
2013
Q4
$1.55M Buy
52,901
+15,101
+40% +$442K ﹤0.01% 1873
2013
Q3
$1.16M Sell
37,800
-129,200
-77% -$3.95M ﹤0.01% 1941
2013
Q2
$5.3M Buy
+167,000
New +$5.3M 0.01% 1075